Cleo Diagnostics Ltd

NEW
ASX:COV (Australia)  
A$ 0.32 -0.025 (-7.35%) Sep 11
At Loss
P/B:
8.51
Market Cap:
A$ 44.85M ($ 32.18M)
Enterprise V:
A$ 38.63M ($ 27.71M)
Volume:
172.26K
Avg Vol (2M):
166.51K
Trade In:
Volume:
172.26K
At Loss
Avg Vol (2M):
166.51K

Cleo Diagnostics Ltd (ASX:COV) Dividend

Cleo Diagnostics Ltd (ASX:COV) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -45%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:COV Dividend

Does Cleo Diagnostics Ltd (ASX:COV) pay a dividend?

Cleo Diagnostics Ltd (ASX:COV) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Cleo Diagnostics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Cleo Diagnostics Ltd has returned capital to shareholders via buybacks at a rate of -45% over the past 3 years.

What are dividend-paying alternatives to Cleo Diagnostics Ltd?

For dividend-paying alternatives in Cleo Diagnostics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.